← Open Payments lookup

CATHY FERNANDEZ: Open Payments

NPI 1184262370 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,908 in 87 payments from 17 companies in 2025. Trend: 2023 $491 · 2024 $986 · 2025 $1,908

Food & beverage: $1,908
CompanyPaymentsAmount
Amgen Inc.22$410
ABBVIE INC.16$344
UCB, Inc.9$267
GENZYME CORPORATION8$244
GlaxoSmithKline, LLC.7$153
Novartis Pharmaceuticals Corporation4$102
Mallinckrodt Hospital Products Inc.5$84
Janssen Biotech, Inc.4$63
E.R. Squibb & Sons, L.L.C.2$44
Aurinia Pharma U.S., Inc.2$43

Products named: Bimzelx, KEVZARA, RINVOQ, KRYSTEXXA, BENLYSTA, SKYRIZI, OTEZLA, ACTHAR.

Industry payments across TX — which companies pay providers there.